Leerink Partnrs Has Bullish Forecast for LXEO Q2 Earnings
Lexeo Therapeutics, Inc. (NASDAQ:LXEO – Free Report) – Research analysts at Leerink Partnrs raised their Q2 2025 earnings per share estimates for Lexeo Therapeutics in a report released on Tuesday, May 27th. Leerink Partnrs analyst M. Foroohar now anticipates that the company will post earnings of ($0.45) per share for the quarter, up from their […]
Lexeo Therapeutics, Inc. (NASDAQ:LXEO – Free Report) – Research analysts at Leerink Partnrs raised their Q2 2025 earnings per share estimates for Lexeo Therapeutics in a report released on Tuesday, May 27th. Leerink Partnrs analyst M. Foroohar now anticipates that the company will post earnings of ($0.45) per share for the quarter, up from their […]
